Paul Grootendorst
Impact in
- Family Practice top 1%
- Medication Adherence and Compliance
- Statistics and Probability top 1%
- Advanced Causal Inference Techniques
- Statistical Methods and Inference
- Statistical Methods and Bayesian Inference
Papers in
-
- Health Systems, Economic Evaluations, Quality of Life 53
- Pharmaceutical Economics and Policy 42
- Healthcare Policy and Management 24
- Innovation Policy and R&D 7
- Co-authors
- Geoffrey M. AndersonPeter C. AustinJoel LexchinAdrian R. LevyBernie J. OʼBrienDavid FeenyWilliam FurlongDonald J. Willison
- Journals
- Canadian Medical Association Journal (5 papers)Health Policy (5 papers)Value in Health (5 papers)Health Economics (4 papers)Canadian Pharmacists Journal / Revue des Pharmaciens du Canada (4 papers)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Paul Grootendorst
112 papers receiving 3.8k citations
Hit Papers
Peers
Comparison fields: 5 of 177
- Family Practice 243
- Statistics and Probability 453
- Economics and Econometrics 1.5k
- Geriatrics and Gerontology 161
- Applied Microbiology and Biotechnology 56
Countries citing papers authored by Paul Grootendorst
This map shows the geographic impact of Paul Grootendorst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Grootendorst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Grootendorst more than expected).
Fields of papers citing papers by Paul Grootendorst
This network shows the impact of papers produced by Paul Grootendorst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Grootendorst. The network helps show where Paul Grootendorst may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Paul Grootendorst, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2023 | 3 | |
| 4 | 2023 | 2 | |
| 5 | 2019 | 64 | |
| 6 | 2018 | 6 | |
| 7 | Patents, Public-Private Partnerships or Prizes – How should we support pharmaceutical innovation? | 2009 | 2 |
| 8 | 2009 | 4 | |
| 9 | Dental insurance, income and the use of dental care in Canada. | 2007 | 87 |
| 10 | Effects of 'Authorized-Generics' on Canadian Drug Prices | 2007 | 1 |
| 11 | 2007 | 60 | |
| 12 | A review of instrumental variables estimation in the applied health sciences | 2007 | 4 |
| 13 | 2006 | 176 | |
| 14 | Can current electronic systems meet drug safety and effectiveness requirements? | 2005 | 7 |
| 15 | Resistance to antibiotics: administrative response to the challenge. | 2004 | 3 |
| 16 | The Impact of Differential Cost Sharing of Non-Steroidal Anti-Inflammatory Agents on the Use and Costs of Analgesic Drugs | 2004 | 5 |
| 17 | Impact of reference-based pricing of nitrates on the use and costs of anti-anginal drugs. | 2001 | 50 |
| 18 | 2000 | 179 | |
| 19 | 1997 | 88 | |
| 20 | Does it matter whom and how you ask? | 1994 | 1 |
About Paul Grootendorst
Paul Grootendorst is a scholar working on Family Practice, Economics and Econometrics, Applied Microbiology and Biotechnology, Geriatrics and Gerontology and Management of Technology and Innovation, having authored 120 papers that have together received 4.0k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (53 papers), Pharmaceutical Economics and Policy (42 papers), Healthcare Policy and Management (24 papers), Intellectual Property and Patents (11 papers), Pharmaceutical industry and healthcare (8 papers), Primary Care and Health Outcomes (8 papers), Innovation Policy and R&D (7 papers) and Advanced Causal Inference Techniques (7 papers). The work is most often cited by research in Family Practice (243 citations), Statistics and Probability (453 citations), Economics and Econometrics (1.5k citations), Geriatrics and Gerontology (161 citations) and Applied Microbiology and Biotechnology (56 citations). Paul Grootendorst has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Geoffrey M. Anderson, Peter C. Austin, Joel Lexchin, Adrian R. Levy, Bernie J. OʼBrien, David Feeny, William Furlong, Donald J. Willison, Connie Sellors and Devon Greyson. Their work appears in journals such as Canadian Medical Association Journal, Health Policy, Value in Health, Health Economics and Canadian Pharmacists Journal / Revue des Pharmaciens du Canada.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.